Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARAMIS: Randomized Multicenter Study for Isolated Skin Vasculitis
jRCTs051190112Completed
- Start
- Jun 2020
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Randomised trial of colchicine, dapsone and azathioprine in cutaneous vasculitis (CSVV), cutaneous leukocytoclastic vasculitis (LCV), cutaneous arteritis (cPAN) and 2 more (6 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2020; status: completed.
02
Drugs
colchicinedapsoneazathioprine
03
Conditions
cutaneous vasculitis (CSVV)cutaneous leukocytoclastic vasculitis (LCV)cutaneous arteritis (cPAN)polyarteritis nodosa (PAN)Henoch-Schönlein Purpura (HSP)
Beyond the preview
Go deeper on jRCTs051190112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190112.